Pharma Times
Subscription Required: Yes
Pharma Time delivers the latest updates, analysis, and insights on pharmaceutical industry developments, research, and policy changes.
Latest News
- RougeTx launches with $58 million series A financing for HHT therapy
- Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
- Bespak and SNBL agree global access deal for FDA‑approved nasal device
- NEMLUVIO data show sustained three‑year responses in atopic dermatitis
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
- MINT study results strengthen real‑world evidence for mogamulizumab
- SMC accepts vutrisiran for eligible patients in Scotland